Avalo Therapeutics, Inc. (AVTX) Earnings
NASDAQ·Healthcare·Biotechnology
$16.16
-5.94%
Mkt Cap $1.04B
EPS — Estimate vs Actual
Mkt Cap
$1.04B
P/E
—
Fwd P/E
—
P/S
17560.50
Rev TTM
—
EPS TTM
-$5.83
NASDAQ·Healthcare·Biotechnology
$16.16
-5.94%
Mkt Cap $1.04B
Mkt Cap
$1.04B
P/E
—
Fwd P/E
—
P/S
17560.50
Rev TTM
—
EPS TTM
-$5.83